| # | Title | Journal | Year | Citations |
|---|
| 1 | Pharmacological and Therapeutic Properties of Valproate | CNS Drugs | 2002 | 561 |
| 2 | Clinically relevant drug interactions with antiepileptic drugs | British Journal of Clinical Pharmacology | 2006 | 502 |
| 3 | Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID‐19 | Journal of Ultrasound in Medicine | 2020 | 483 |
| 4 | Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs | Lancet Neurology, The | 2003 | 447 |
| 5 | Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs | Lancet Neurology, The | 2003 | 359 |
| 6 | State of the art paper Sulfonylureas and their use in clinical practice | Archives of Medical Science | 2015 | 351 |
| 7 | Idiosyncratic Adverse Reactions to Antiepileptic Drugs | Epilepsia | 2007 | 321 |
| 8 | The Efficacy of Valproate-Lamotrigine Comedication in Refractory Complex Partial Seizures: Evidence for a Pharmacodynamic Interaction | Epilepsia | 1999 | 291 |
| 9 | Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practice | Archives of Medical Science | 2012 | 291 |
| 10 | Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine | Clinical Pharmacokinetics | 1996 | 284 |
| 11 | Effects of insufficient sleep on blood pressure in hypertensive patients A 24-h study | American Journal of Hypertension | 1999 | 271 |
| 12 | The pharmacological treatment of epilepsy in adults | Lancet Neurology, The | 2011 | 259 |
| 13 | Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics | Alimentary Pharmacology and Therapeutics | 2004 | 238 |
| 14 | Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry | Epilepsia | 2013 | 232 |
| 15 | Reversible Pseudoatrophy of the Brain and Mental Deterioration Associated with Valproate Treatment | Epilepsia | 1998 | 219 |
| 16 | Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI) | Epilepsy Research | 2013 | 201 |
| 17 | Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study | Diabetes Care | 2020 | 201 |
| 18 | Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study | American Journal of Hypertension | 2001 | 198 |
| 19 | Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug | Lancet Neurology, The | 2016 | 197 |
| 20 | Tiagabine in the treatment of epilepsy — a clinical review with a guide for the prescribing physician | Epilepsy Research | 2000 | 195 |
| 21 | A role for quercetin in coronavirus disease 2019 (COVID‐19) | Phytotherapy Research | 2021 | 193 |
| 22 | Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis | International Journal of Molecular Sciences | 2019 | 183 |
| 23 | Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? | Journal of Epilepsy Research | 2017 | 176 |
| 24 | Pharmacologic Advantages of Antiepileptic Drug Monotherapy | Epilepsia | 1997 | 175 |
| 25 | Birth defects after prenatal exposure to antiepileptic drugs | Lancet Neurology, The | 2005 | 168 |
| 26 | Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly | Autoimmunity Reviews | 2011 | 164 |
| 27 | Anti-obesity drugs: a review about their effects and their safety | Expert Opinion on Drug Safety | 2012 | 162 |
| 28 | Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII) | Epilepsy Research | 2015 | 161 |
| 29 | Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects | American Journal of Hypertension | 1996 | 160 |
| 30 | Review article: cardiac adverse effects of gastrointestinal prokinetics | Alimentary Pharmacology and Therapeutics | 1999 | 157 |
| 31 | The Clinical Pharmacokinetics of the Newer Antiepileptic Drugs | Clinical Pharmacokinetics | 1996 | 156 |
| 32 | Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases | Molecular Diagnosis and Therapy | 2016 | 155 |
| 33 | Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials | Expert Opinion on Biological Therapy | 2012 | 150 |
| 34 | Plasticity in the enteric nervous system | Gastroenterology | 1999 | 149 |
| 35 | The long‐term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: The PuLsE (Open Prospective Randomized Long‐term Effectiveness) trial | Epilepsia | 2014 | 149 |
| 36 | Effects of Telmisartan Compared with Eprosartan on Blood Pressure Control, Glucose Metabolism and Lipid Profile in Hypertensive, Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled 12-Month Study | Hypertension Research | 2004 | 148 |
| 37 | Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X) | Epilepsy Research | 2010 | 145 |
| 38 | Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study | ELife | 2021 | 145 |
| 39 | Early acute necrosis, delayed apoptosis and cytoskeletal breakdown in cultured cerebellar granule neurons exposed to methylmercury | ELife | 2000 | 143 |
| 40 | The β3-adrenoceptor as a therapeutic target: Current perspectives | Pharmacological Research | 2009 | 143 |
| 41 | Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists | Journal of Clinical Endocrinology and Metabolism | 2020 | 140 |
| 42 | Matrix Metalloproteinase-2 and -9 Levels in Obese Patients | Endothelium: Journal of Endothelial Cell Research | 2008 | 137 |
| 43 | Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial | Clinical Therapeutics | 2004 | 136 |
| 44 | Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants? | Clinical Pharmacokinetics | 2000 | 135 |
| 45 | An Introduction to Antiepileptic Drugs | Epilepsia | 2005 | 135 |
| 46 | 30 years of second-generation antiseizure medications: impact and future perspectives | Lancet Neurology, The | 2020 | 134 |
| 47 | A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers | Journal of Ethnopharmacology | 1986 | 131 |
| 48 | Irritable Bowel Syndrome | Drugs | 2001 | 128 |
| 49 | Adverse effects of antiepileptic drugs | Acta Neurologica Scandinavica | 2005 | 123 |
| 50 | Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men | European Journal of Clinical Pharmacology | 2002 | 120 |
